Wu S - Search Results

1

ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16^INK4a levels.

Hao X, Shiromoto Y, Sakurai M, Towers M, Zhang Q, Wu S, Havas A, Wang L, Berger S, Adams PD, Tian B, Nishikura K, Kossenkov AV, Liu P, Zhang R. Hao X, et al. Among authors: wu s. Nat Cell Biol. 2022 Aug;24(8):1202-1210. doi: 10.1038/s41556-022-00959-z. Epub 2022 Jul 18. Nat Cell Biol. 2022. PMID: 35851616 Free PMC article.

2

Arid1a controls tissue regeneration.

Wu S, Zhang R, Bitler BG. Wu S, et al. Stem Cell Investig. 2016 Aug 9;3:35. doi: 10.21037/sci.2016.07.07. eCollection 2016. Stem Cell Investig. 2016. PMID: 27582418 Free PMC article. No abstract available.

3

ARID1A-mutated ovarian cancers depend on HDAC6 activity.

Bitler BG, Wu S, Park PH, Hai Y, Aird KM, Wang Y, Zhai Y, Kossenkov AV, Vara-Ailor A, Rauscher FJ III, Zou W, Speicher DW, Huntsman DG, Conejo-Garcia JR, Cho KR, Christianson DW, Zhang R. Bitler BG, et al. Among authors: wu s. Nat Cell Biol. 2017 Aug;19(8):962-973. doi: 10.1038/ncb3582. Epub 2017 Jul 24. Nat Cell Biol. 2017. PMID: 28737768 Free PMC article.

4

Harnessing mutual exclusivity between TP53 and ARID1 A mutations.

Wu S, Fatkhutdinov N, Zhang R. Wu S, et al. Cell Cycle. 2017;16(24):2313-2314. doi: 10.1080/15384101.2017.1377503. Cell Cycle. 2017. PMID: 29279027 Free PMC article. No abstract available.

5

CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.

Karakashev S, Zhu H, Wu S, Yokoyama Y, Bitler BG, Park PH, Lee JH, Kossenkov AV, Gaonkar KS, Yan H, Drapkin R, Conejo-Garcia JR, Speicher DW, Ordog T, Zhang R. Karakashev S, et al. Among authors: wu s. Nat Commun. 2018 Feb 12;9(1):631. doi: 10.1038/s41467-018-03031-3. Nat Commun. 2018. PMID: 29434212 Free PMC article.

6

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.

Fukumoto T, Park PH, Wu S, Fatkhutdinov N, Karakashev S, Nacarelli T, Kossenkov AV, Speicher DW, Jean S, Zhang L, Wang TL, Shih IM, Conejo-Garcia JR, Bitler BG, Zhang R. Fukumoto T, et al. Among authors: wu s. Cell Rep. 2018 Mar 27;22(13):3393-3400. doi: 10.1016/j.celrep.2018.03.019. Cell Rep. 2018. PMID: 29590609 Free PMC article.

7

The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II.

Trizzino M, Barbieri E, Petracovici A, Wu S, Welsh SA, Owens TA, Licciulli S, Zhang R, Gardini A. Trizzino M, et al. Among authors: wu s. Cell Rep. 2018 Jun 26;23(13):3933-3945. doi: 10.1016/j.celrep.2018.05.097. Cell Rep. 2018. PMID: 29949775 Free PMC article.

8

SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells.

Wu S, Fatkhutdinov N, Fukumoto T, Bitler BG, Park PH, Kossenkov AV, Trizzino M, Tang HY, Zhang L, Gardini A, Speicher DW, Zhang R. Wu S, et al. Nat Commun. 2018 Oct 8;9(1):4116. doi: 10.1038/s41467-018-06656-6. Nat Commun. 2018. PMID: 30297712 Free PMC article.

9

NAD⁺ metabolism governs the proinflammatory senescence-associated secretome.

Nacarelli T, Lau L, Fukumoto T, Zundell J, Fatkhutdinov N, Wu S, Aird KM, Iwasaki O, Kossenkov AV, Schultz D, Noma KI, Baur JA, Schug Z, Tang HY, Speicher DW, David G, Zhang R. Nacarelli T, et al. Among authors: wu s. Nat Cell Biol. 2019 Mar;21(3):397-407. doi: 10.1038/s41556-019-0287-4. Epub 2019 Feb 18. Nat Cell Biol. 2019. PMID: 30778219 Free PMC article.

10

N⁶-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance.

Fukumoto T, Zhu H, Nacarelli T, Karakashev S, Fatkhutdinov N, Wu S, Liu P, Kossenkov AV, Showe LC, Jean S, Zhang L, Zhang R. Fukumoto T, et al. Among authors: wu s. Cancer Res. 2019 Jun 1;79(11):2812-2820. doi: 10.1158/0008-5472.CAN-18-3592. Epub 2019 Apr 9. Cancer Res. 2019. PMID: 30967398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,179 results

Search Page